Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

AHRQ names director of Center for Delivery, Organization, and Markets

David Knutson, MS, has been named director of the Agency for Healthcare Research and Quality (AHRQ)’s Center for Delivery, Organization, and Markets.

Florida Hospital DeLand names new CEO

Lorenzo Brown has been named the new CEO of Florida Hospital DeLand in DeLand, Fla. The move is effective May 1. 

Sync for Science pilot launches

The Sync for Science pilot, announced during the White House’s Precision Medicine Initiative Summit, has begun.

Thumbnail

Economics experts reveal the best and worst places for doctors in 2016

With both the least competition and the highest mean annual pay (after adjustment for cost of living), Mississippi has emerged as the best place to practice medicine in the U.S., according to an analysis by WalletHub. 

Report: CEOs detail 3 determining factors for healthcare success

A new report comprised of insights from healthcare CEOs highlights three specific factors necessary to compete in the ever-evolving medical industry.

Looking at the ACA, 6 years later

President Obama’s Affordable Care Act (ACA) was signed into law on March 23, 2010, and a recent editorial in the Wall Street Journal examined the law’s impact after six years.

Report: Universal Health Services CEO is worth $1.1 billion

Alan Miller, the CEO of Universal Health Services, Inc., for the past 37 years, has a net worth of $1.1 billion, according to a BloombergBusiness article.

Book explores impact of internet use on healthcare

The author of a new book looks at how internet searches are impacting medical research.

Displaying 6233 - 6240 of 8453

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.